C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2001
10/25/2001	US20010034438 24 contiguous bases of nucleotide sequence in the G-protein coupled receptor polynucleotide sequence
10/25/2001	US20010034437 Structural similarity with animal proteases like enteropep-tidase, plasminogen and acrosin; modulaters of the expression or activity of the proteins can be used for drug screening, medical diagnosis and physiological disorder treatment
10/25/2001	US20010034436 Polynucleotide and polypeptides, screening for antibiotic activity, Staphylococcus
10/25/2001	US20010034435 Process and equipment for plasmid purification
10/25/2001	US20010034433 Inhibition of growth of somatomedin dependent cancers, the effect of somatomedin-c in acromegaly, the growth of retinal blood vessels and fibrous tissues in diabetic retinopathy, growth of tall children, etc.; antiscarring agents
10/25/2001	US20010034337 Antiproliferative agents
10/25/2001	US20010034334 Genetic engineered polypeptide
10/25/2001	US20010034331 Isolated polypeptide
10/25/2001	US20010034329 Nucleic acids
10/25/2001	US20010034062 For engineering cells for delivery of antibodies to combat respiratory diseases, viral infection, asthma, allergy, and macular degeneration
10/25/2001	US20010034054 Producing replication-defective adeno-associated virons(AAV) free of wild-type AAV and helper adenovirus by introducing into a host cell an AAV vector, an AAV helper construct and an adenoplasmid accessory construct; unpackageable; lysis
10/25/2001	US20010034050 Fusion peptides isolatable by phase transition
10/25/2001	US20010034049 A protein having xylitol dehydrogenase activity i.e. catalyses producing xylitol from xylose, a DNA which codes for the protein and a cell which is cultivated in a medium to produce the protein; artificial sweeteners; anticaries agents
10/25/2001	US20010034048 Complementary to a target polynucleotide sequence by hybridizing a single stranded DNA target template with a composite primer comprising an RNA protion and a 3'DNA portion; extending with a polymerase; cleaving the RNA
10/25/2001	US20010034046 Production of 8,8a-dihydroxy-6-deoxyerythronolide B
10/25/2001	US20010034045 Inducing an elevated unfolded protein response by using an isolated heterologous nucleic acid endocing a HAC1 protein, a PTC2 protein or an 1re1 protein
10/25/2001	US20010034044 Genomic sequences for protein production and delivery
10/25/2001	US20010034043 Useful as a host cell for expression of recombinant DNA sequences; expression of homologous and heterologous genes in F. heparinum and the coupling of expression to secretion of biologically active polypeptides or protein
10/25/2001	US20010034040 Growing a mycelia-producing cell type to allow it to produce a biomolecule or biactivity; screening for the bioactivity or biomolecule using a fluorescence analyzer; identifying clones from an expression library using a fluorescent activated cell
10/25/2001	US20010034038 Isolated ductal fluid sample
10/25/2001	US20010034035 Amino acid sequences derived partially from ependymin that binds with calcium; stroke and other neurodegenerative diseases; antiischemic agents; cognition activators; conjugated to transfer through blood-brain barrier
10/25/2001	US20010034033 Nucleic acid mediated electron transfer
10/25/2001	US20010034032 Determining a subject's susceptibility to or the rapidity of progression of sepsis in a subject by detecting at least one allele of an Interleukin-1 proinflammatory haplotype in a nucleic acid sample which indicates increased susceptibility
10/25/2001	US20010034031 Coencapsulating the agent being screened with a first protein linked to a DNA and a second protein linked to a transcriptional activation moiety to determine modulation by the agent; fluorescense-activated cell sorting; libraries
10/25/2001	US20010034030 Acquiring a spectrum for a hybridization complex formed between a nucleic acid probe electromagnetically coupled to a portion of a signal path and a nucleic acid target by propagating a test signal and detecting hybridization signal
10/25/2001	US20010034029 Fluorescent oligonucleotides are hybridized with corresponding ones of the inspected sites of the object of analysis, a homoduplex is formed having normal base sequence, and heteroduplex is formed having mutational base sequence
10/25/2001	US20010034028 Introducing to the genome of test cell a polynucleotide construct, encodes an assay marker peptide, sorting the cell based upon expression of assay marker peptide, correlating expression with genetic locus, comparing with reference cell
10/25/2001	US20010034027 Microarray, method for producing the same, and method for correcting inter-pin spotting amount error of the same
10/25/2001	US20010034024 Mutations in and genomic structure of HERG - a long QT syndrome gene
10/25/2001	US20010034022 Providing a sample suspected of containing enterovirus and a mixed cell culture comprising Rhabdomyosarcoma cells and human mucoepidermoid cells, inoculating mixed cell culture with sample, observing inoculated culture for enterovirus
10/25/2001	US20010034021 Antibodies that specifically react with seroreactive regions on HPV 16 proteins E1 and E2
10/25/2001	US20010034018 Contacting a sample with an antibody which binds to SVI (Sentinel virus 1) or a protein and the antibody does not bind TTV strains SANBAN and TUS01 or protiens and detecting the complexes of antibody and SVI virus or protein
10/25/2001	US20010033845 Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
10/25/2001	EP1144653A3 THERMOSTABLE ENZYME PROMOTING THE FIDELITY OF THERMOSTABLE DNA POLYMERASES- FOR IMPROVEMENT OF NUCLEIC ACID SYNTHESIS AND AMPLIFICATION i IN VITRO /i
10/25/2001	DE10020125A1 Agent for stimulating bone regrowth, useful as insert after surgery for bone cancer, comprises single sequence expressing a fusion of growth factor and protease inhibitor
10/25/2001	DE10019967A1 New recombinant antibody specific for native gp96, useful for isolating gp96 as complex with endogenous peptides, used for autologous immunotherapy of e.g. tumor
10/25/2001	DE10019901A1 New isolated nucleic acid encoding an apoptase, useful e.g. for diagnosis and treatment of apoptosis-related, especially neurodegenerative, diseases
10/25/2001	DE10019195A1 Gene complex for reversible cell immortalization, useful for expanding cells for cell replacement therapy of e.g. neurodegenerative disease, contains removable immortalizing gene
10/25/2001	DE10019120A1 New human platelet-activating factor (PAF) receptor-2 gene, useful for diagnosis and treatment of PAF-related diseases
10/25/2001	DE10018368A1 Screening for kinase able to phosphorylate 1-deoxy-D-xylulose, useful for producing the 5-phosphate, an intermediate for vitamins and terpenoids
10/25/2001	CA2798625A1 Novel methods of constructing libraries of genetic packages that collectively display the members of a diverse family of peptides, polypeptides or proteins
10/25/2001	CA2747325A1 Albumin fusion proteins
10/25/2001	CA2409190A1 Poliovirus replicons encoding therapeutic agents and uses thereof
10/25/2001	CA2406955A1 Sheep lice, bovicola ovis, allergen treatment
10/25/2001	CA2406590A1 Agent for postoperative use after the removal of bone tumours
10/25/2001	CA2406566A1 Lactic acid bacteria overproducing exopolysaccharides
10/25/2001	CA2406481A1 Trp8, a transient receptor potential channel expressed in taste receptor cells
10/25/2001	CA2406472A1 Javelinization of protein antigens to heat shock proteins
10/25/2001	CA2406403A1 Tissue-specific and pathogen-specific toxic agents, ribozymes, dnazymes and antisense oligonucleotides, and methods of use thereof
10/25/2001	CA2406390A1 Cloning, overexpression and therapeutic uses of bioactive histidine ammonia lyase
10/25/2001	CA2406378A1 Targeted vaccine delivery systems
10/25/2001	CA2406346A1 Genetic testing for determining the risk of pouchitis development
10/25/2001	CA2406308A1 Method and apparatus for selective biological material detection
10/25/2001	CA2406213A1 Compositions and methods for the therapy and diagnosis of breast cancer
10/25/2001	CA2406196A1 Therapeutic uses for mesenchymal stromal cells
10/25/2001	CA2406195A1 Lipid binding protein 4
10/25/2001	CA2406192A1 Therapeutic compounds and methods for formulating v3, a versican isoform
10/25/2001	CA2406180A1 Viruses comprising mutant ion channel protein
10/25/2001	CA2406171A1 Reversible immortalization of cells
10/25/2001	CA2406140A1 Methods for measuring drug resistance
10/25/2001	CA2406126A1 Humar emr2, a g-protein coupled receptor from the egf-tm7 family
10/25/2001	CA2406096A1 Degradable nucleic acid probes and nucleic acid detection methods
10/25/2001	CA2406090A1 Medicine response assay in respiratory disease
10/25/2001	CA2406087A1 New lipid binding protein 2
10/25/2001	CA2406076A1 Process for modifying plants
10/25/2001	CA2406066A1 Lipid binding protein 3
10/25/2001	CA2405954A1 Novel expression-regulating sequences and expression products in the field of filamentous fungi
10/25/2001	CA2405781A1 Secreted proteins
10/25/2001	CA2405768A1 Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same
10/25/2001	CA2405753A1 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
10/25/2001	CA2405729A1 Human metalloprotease and polynucleotides encoding the same
10/25/2001	CA2405711A1 Live cell procedures to identify compounds modulating intracellular distribution of phosphodiesterase (pde) enzymes
10/25/2001	CA2405709A1 Albumin fusion proteins
10/25/2001	CA2405701A1 Albumin fusion proteins
10/25/2001	CA2405563A1 Albumin fusion proteins
10/25/2001	CA2405560A1 Nucleic acid sequences to proteins involved in tocopherol synthesis
10/25/2001	CA2405557A1 Albumin fusion proteins
10/25/2001	CA2405555A1 Pluripotent cells comprising allogenic nucleus and mitochondria
10/25/2001	CA2405550A1 Albumin fusion proteins
10/25/2001	CA2405525A1 Albumin fusion proteins
10/25/2001	CA2405456A1 Detection and amplification of rna using target-mediated ligation of dna by rna ligase
10/25/2001	CA2405451A1 Molecules associated with human reproduction
10/25/2001	CA2405440A1 Compositions and methods for induction of proteins involved in xenobiotic metabolism
10/25/2001	CA2405412A1 Method of designing addressable array for detection of nucleic acid sequence differences using ligase detection reaction
10/25/2001	CA2405078A1 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
10/25/2001	CA2404129A1 Codon optimisation for expression in retrovirus packaging cells
10/25/2001	CA2404127A1 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor
10/25/2001	CA2403644A1 Drug metabolizing enzymes
10/25/2001	CA2403547A1 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
10/25/2001	CA2403508A1 Extracellular matrix polynucleotides, polypeptides, and antibodies
10/25/2001	CA2400635A1 Cellular arrays for the identification of altered gene expression
10/25/2001	CA2399940A1 Enhancement of antibody-mediated immune responses
10/25/2001	CA2376882A1 Novel recombinant antibody, amino acid sequences of its complementarity determining regions and genes encoding the same
10/25/2001	CA2376552A1 High-throughput screening of expressed dna libraries in filamentous fungi
10/25/2001	CA2370572A1 Kv10.1, a novel voltage-gated potassium channel from human brain
10/24/2001	EP1148143A2 Cytochrome p450 monooxygenase and NADPH cytochrome p450 oxidoreductase genes and proteins related to the omega hydroxylase complex of Candida tropicalis and methods relating thereto
10/24/2001	EP1148139A1 Variant luciferase, variant luciferase gene, novel recombinant dna and process for producing variant luciferase
10/24/2001	EP1148138A2 Cytochrome P450 monooxygenase and NADPH cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of Candida tropicalis and methods thereto
10/24/2001	EP1148137A2 Cytochrome P450 monooxygenase and NADPH cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of Candida tropicalis and methods relating thereto
10/24/2001	EP1148136A2 Cytochrome P450 monooxygenase and NADPH cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of Candida tropicalis and methods relating thereto

1 ... 2956 2957 2958 2959 2960 2961 2962 2963 2964 2965 2966 2967 2968 2969 2970 2971 2972 2973 2974 2975 2976 ... 4023